Clinical Trial Detail

NCT ID NCT01599832
Title Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

clear cell renal cell carcinoma

Therapies

Pazopanib

Age Groups: adult

No variant requirements are available.